Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00055718
First received: March 6, 2003
Last updated: December 17, 2013
Last verified: May 2006